Cyclomics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)

  • Latest Deal Amount
  • $3.05M

  • Investors
  • 3

Cyclomics General Information

Description

Operator of molecular diagnostic technology intended to support cancer detection and intraoperative tumour classification. The company offers nanopore sequencing, circulating tumour DNA analysis, DNA methylation profiling, and deep learning-based tumour classification tools, enabling researchers, pathologists, and surgical teams to perform non-invasive cancer monitoring and real-time molecular diagnostic assessment.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Venture Capital-Backed
Corporate Office
  • Matrix ONE building
  • Science Park 301
  • 1098 XH Amsterdam
  • Netherlands
Primary Industry
Biotechnology
Parent Company
Corporate Office
  • Matrix ONE building
  • Science Park 301
  • 1098 XH Amsterdam
  • Netherlands

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Cyclomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
8. Later Stage VC 07-Jan-2026 $3.05M Cancelled Generating Revenue
7. Accelerator/Incubator 07-Oct-2024 Completed Generating Revenue
6. Merger/Acquisition 01-Feb-2024 Completed Generating Revenue
5. Seed Round 03-Mar-2023 Completed Generating Revenue
4. Merger/Acquisition 13-Feb-2024 Cancelled Generating Revenue
3. Grant 01-Mar-2019 Completed Generating Revenue
2. Grant 01-Nov-2017 $29.4K Completed Generating Revenue
1. University Spin-Out 01-Nov-2017 Completed Generating Revenue
To view Cyclomics’s complete valuation and funding history, request access »

Cyclomics Patents

Cyclomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025127927-A1 Method for sequencing nucleic acid molecules and related methods Inactive 12-Dec-2023

Cyclomics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Cyclomics Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Horizon 2020 Government
LifeSciences@Work Accelerator/Incubator
UMC Utrecht University
To view Cyclomics’s complete investors history, request access »

Cyclomics FAQs

  • When was Cyclomics founded?

    Cyclomics was founded in 2017.

  • Where is Cyclomics headquartered?

    Cyclomics is headquartered in Amsterdam, Netherlands.

  • What is the size of Cyclomics?

    Cyclomics has 10 total employees.

  • What industry is Cyclomics in?

    Cyclomics’s primary industry is Biotechnology.

  • Is Cyclomics a private or public company?

    Cyclomics is a Private company.

  • What is Cyclomics’s current revenue?

    The current revenue for Cyclomics is .

  • Who are Cyclomics’s investors?

    Horizon 2020, LifeSciences@Work, and UMC Utrecht have invested in Cyclomics.

  • When was Cyclomics acquired?

    Cyclomics was acquired on 07-Jan-2026.

  • Who acquired Cyclomics?

    Cyclomics was acquired by Lunai Bioworks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process